An Ophthalmic Safety Study in Patients with Breast Cancer

Study identifier:D853AC00001

ClinicalTrials.gov identifier:NCT06767462

EudraCT identifier:N/A

CTIS identifier:2024-512161-14-00

Will Be Recruiting

Official Title

A Multicentre Study Assessing Ophthalmic Safety in Patients with Breast Cancer

Medical condition

Ophthalmic Safety in Patients with Breast Cancer

Phase

Phase 1

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

160

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 27 Jan 2025
Estimated Primary Completion Date: 31 May 2027
Estimated Study Completion Date: 31 May 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Other

Verification:

Verified 01 Jan 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria